Biomarker-positive EGFR/HER2- Expressing HNSCC
1 clinical trials · Condition
◉ Watch Biomarker-positive EGFR/HER2- Expressing HNSCC
| Record | Firm | Date |
|---|---|---|
| EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC (NCT07617805) | Beijing Biotech | 2026-03-02 |
Track Biomarker-positive EGFR/HER2- Expressing HNSCC automatically
Every clearance here is in the API, with alerts when new ones post.